www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
MANAGEMENT TEAM
 BOARD OF DIRECTORS
INVESTOR RELATIONS
CONTACT

 
 
James R. Murphy
Director and non-executive Chairman of the Board

Mr. Murphy has served as our non-executive Chairman of the Board since the spin-off from Bentley in 2008. Mr. Murphy was one of Bentley’s directors from 1993 until the spin-off. Mr. Murphy was President of Bentley from September 1994 until August 2005, was named Chief Executive Officer and Chairman of the Board in 1995. Prior to rejoining Bentley, Mr. Murphy served as Vice President of Business Development at MacroChem Corporation, a publicly owned pharmaceutical and drug delivery company, from March 1993 through September 1994. From September 1992 until March 1993, Mr. Murphy previously served as a consultant in the pharmaceutical industry and he spent 14 years in pharmaceutical research and product development with SmithKline Corporation and in international business development with contract research and consulting laboratories. Mr. Murphy received a B.A. in Biology from Millersville University.
 
John A. Sedor
Director, President and Chief Executive Officer

Mr. Sedor was elected to the Board of Directors in 2009 and has been our President and Chief Executive Officer since the spin-off from Bentley in 2008. Mr. Sedor was President of Bentley from 2005 until the spin-off. From 2001 to May 2005, he was President and CEO of Sandoz, Inc. (a division of Novartis AG). From 1998-2001 Mr. Sedor was President and Chief Executive Officer at Verion, Inc., a drug delivery company. Previously, Mr. Sedor served as President and Chief Executive Officer at Centeon, LLC, a joint venture between two major multinational corporations, Rhône-Poulenc Rorer and Hoechst AG. Previously, Mr. Sedor served as Executive Vice President at Rhône-Poulenc Rorer, Revlon Health Care and Parke-Davis. Mr. Sedor holds a Bachelor of Science degree in Pharmacy/Chemistry from Duquesne University, and has studied strategic marketing at both Northwestern University’s Kellogg Graduate School of Management and Harvard Business School. He has also attended Harvard’s Executive Forum.
 
Michael McGovern
Director

Mr. McGovern has served as one of our directors since the spin-off from Bentley in 2008. Mr. McGovern was one of Bentley’s directors from 1997 until the spin-off and was named Vice Chairman of Bentley in October 1999. Mr. McGovern serves as President of McGovern Enterprises, a provider of corporate and financial consulting services, which he founded in 1975. Mr. McGovern is Chairman of the Board of Training Solutions Interactive, Inc., Vice Chairman of the Board of Employment Technologies, Inc., and a Director on the corporate board of the Reynolds Development Company. Mr. McGovern received a B.S. and M.S. in accounting and his Juris Doctor from the University of Illinois. Mr. McGovern is a Certified Public Accountant.
 
Miguel Fernandez
Director

Mr. Fernandez has served as one of our directors since the spin-off from Bentley in 2008. Mr. Fernandez served as a Bentley director from 1999 until the spin-off. Mr. Fernandez served from 1980 to 1996 as President of the International Division and corporate Vice President at Carter-Wallace, Inc., where he was responsible for all product lines outside of the United States. Previously, Mr. Fernandez was employed for approximately eight years by SmithKline & French, where his last position was President of the division that included France, Portugal and Switzerland. Mr. Fernandez attended the University of British Columbia in Canada and received an M.B.A. from the Ivey School of Business at the University of Western Ontario in London, Ontario, Canada. Mr. Fernandez has been retired since 1996.
 
John W. Spiegel
Director

Mr. Spiegel has served in this role for CPEX since the spin-off from Bentley in 2008. Mr. Spiegel served as a Bentley director from 2002 until the spin-off. Mr. Spiegel served as Vice Chairman and Chief Financial Officer of Sun Trust Banks, Inc. from August 2000 until he retired as Chief Financial Officer in 2004 and as Vice Chairman in 2005. From 1985 to August 2000, Mr. Spiegel was an Executive Vice President and Chief Financial Officer of Sun Trust Banks. Mr. Spiegel also serves on the Board of Directors of Rock-Tenn Company, S1 Corporation and Colonial Properties Trust, all public companies and is a member of the Dean’s Advisory Council of the Goizueta Business School at Emory University. Mr. Spiegel received an M.B.A. from Emory University.
 
 
 
FEBRUARY 01, 2010
CPEX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW CHIEF SCIENTIFIC OFFICER
 
JANUARY 08, 2010
CPEX PHARMACEUTICALS REPORTS ON SEC FILING BY ARCADIA CAPITAL ADVISORS
 
DECEMBER 21, 2009
CPEX PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2A CLINICAL TRIAL OF NASULIN™
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101